Implantable Drug Delivery Devices Market Forecasts Robust Growth with Advanced Biocompatible Material Innovations
24 janv. 2024 19h56 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Implantable Drug Delivery Devices Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The implantable drug delivery...
Drug Delivery Companies Compendium Directory 2024
19 janv. 2024 09h08 HE
|
Research and Markets
Dublin, Jan. 19, 2024 (GLOBE NEWSWIRE) -- The "Drug Delivery Companies Compendium 2024" directory has been added to ResearchAndMarkets.com's offering.Accurate and timely intelligence about the drug...
Global Long-Acting Drug Delivery Technologies and Services Market 2023-2033: Navigating Regulatory Complexities, Key to Success
22 déc. 2023 10h08 HE
|
Research and Markets
Dublin, Dec. 22, 2023 (GLOBE NEWSWIRE) -- The "Long-Acting Drug Delivery Technologies and Services Market: A Global and Regional Analysis, 2023-2033" report has been added to ...
Cingulate Receives Guidance from FDA on Path Forward for Anxiety Asset CTx-2103 (buspirone)
01 déc. 2023 09h00 HE
|
Cingulate Inc.
KANSAS CITY, Kan., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
Global Controlled Release Drug Delivery Market Analysis Report 2023-2030 - Growing Application of Non-Invasive Drug Delivery Techniques
28 nov. 2023 07h53 HE
|
Research and Markets
Dublin, Nov. 28, 2023 (GLOBE NEWSWIRE) -- The "Global Controlled Release Drug Delivery Market Size, Share & Industry Trends Analysis Report By Release Mechanism, By Technology, By Application,...
Cingulate to Host CNS Key Opinion Leader Panel in New York City
17 oct. 2023 14h22 HE
|
Cingulate Inc.
KANSAS CITY, Kan., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
Global Controlled Release Drugs Delivery Market Set to Exceed $100 Billion by 2029: Pharma Firms Embrace Innovations to Tackle Generic Competition
25 sept. 2023 06h53 HE
|
Research and Markets
Dublin, Sept. 25, 2023 (GLOBE NEWSWIRE) -- The "Global Controlled Release Drug Delivery Market, Drug Dosage, Price and Clinical Pipeline Insight 2029" drug pipelines has been added to ...
Cingulate Inc. to Present at the LD Micro Main Event XVI
21 sept. 2023 13h30 HE
|
Cingulate Inc.
KANSAS CITY, Kan., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ:CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
Cingulate Announces Closing of $4.0 Million Public Offering
13 sept. 2023 16h15 HE
|
Cingulate Inc.
KANSAS CITY, Kan., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING) (“Cingulate,” the “Company,” “we,” “our” or “us”), a biopharmaceutical company utilizing its proprietary Precision...
Cingulate Announces Pricing of $4.0 Million Public Offering
11 sept. 2023 09h22 HE
|
Cingulate Inc.
KANSAS CITY, Kan., Sept. 11, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING) (“Cingulate,” the “Company,” “we,” “our” or “us”), a biopharmaceutical company utilizing its proprietary...